TipRanks
Relmada Therapeutics Inc (DE:4E2)
NASDAQ:4E2

Relmada Therapeutics (4E2) Revenue

0 Followers

Relmada Therapeutics Revenue

Relmada Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Relmada Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
€0
Employees
17
Market Cap
€307.80M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―――
Dec 31, 2024
―――
Dec 31, 2023
―――
Dec 31, 2022
―――
Dec 31, 2021
―――
Dec 31, 2020
―――
Dec 31, 2019
―――
Jun 30, 2019
―――
Jun 30, 2018
―――